gestion_de_la_pandemia
Administrador de Ficheros
Espacios de nombres
Escoge "espacio de nombre"
Archivos Multimedia
Ficheros en wiki:vacunas:eficacia_y_efectividad
- alarming_antibody_evasion_properties_of_rising_sars-cov-2_bq_and_xbb_subvariants.pdf
- 2023/04/28 19:45
- 4.5 MB
- antibody_responses_to_omicron_ba.4_ba.5_bivalent_mrna_vaccine_booster_shot.pdf
- 2023/04/28 19:45
- 256.6 KB
- association_between_mrna_vaccination_and_covid-19_hospitalization.pdf
- 2023/04/28 19:45
- 516.3 KB
- bnt162b2_mrna_covid-19_vaccine_in_a_nationwide_mass_vaccination_setting.pdf
- 2023/07/01 21:49
- 540.3 KB
- breakthrough_sars-cov-2_infections_in_620_000_u.s._veterans_.pdf
- 2023/04/28 19:45
- 843.8 KB
- cdc_covid-19_cases_and_hospitalizations_by_covid-19_vaccination_status.pdf
- 2023/04/28 19:45
- 303.1 KB
- covid-19_vaccine_efficacy_and_effectiveness_the_elephant.pdf
- 2023/04/28 19:45
- 402.9 KB
- discrepancies_and_inconsistencies_in_uk_government_datasets_compromise.pdf
- 2023/04/28 19:45
- 725.7 KB
- doesth_1.pdf
- 2024/06/29 22:44
- 859.8 KB
- efectividad_de_la_vacuna_bnt162b2_centro_salud_de_javea.pdf
- 2023/04/28 19:45
- 184.8 KB
- effectiveness_of_covid-19_vaccines_against_omicron_or_delta_infection.pdf
- 2023/04/28 19:45
- 383.6 KB
- effectiveness_of_the_coronavirus_disease_2019_covid-19_bivalent_vaccine.pdf
- 2023/04/28 19:45
- 303.2 KB
- effects_of_previous_infection_and_vaccination_on_symptomatic_omicron_infectionsnejm.pdf
- 2023/04/28 19:45
- 714.4 KB
- evaluation_of_a_covid-19vaccine_campaign_and_sars-cov-2_infection_and_mortality.pdf
- 2023/04/28 19:45
- 682.6 KB
- factors_influencing_estimated_effectiveness_of_covid-19_vaccines_in_non-randomised_studies.pdf
- 2023/04/28 19:45
- 175.2 KB
- five_doses_of_the_mrna_vaccination_potentially_suppress_ancestral-strain_stimulated.pdf
- 2023/09/11 18:15
- 1.6 MB
- forgotten_primum_non_nocere_and_increased_mortality_after_covid-19_vaccination.pdf
- 2023/04/28 19:45
- 480.9 KB
- how_vaccination_affects_the_risk_of_long_covid.pdf
- 2023/04/28 19:45
- 339 KB
- imprinted_hybrid_immunity_against_xbb_reinfection.pdf
- 2023/04/28 19:45
- 199.2 KB
- incident_sars-cov-2_infection_mrna-vaccinated_and_unvaccinated_nursing-home_residents.pdf
- 2023/07/07 21:33
- 317.1 KB
- increasing_sars-cov2_cases_hospitalizations_and_deaths_among_the_vaccinated.pdf
- 2023/04/28 19:45
- 2.3 MB
- miscategorisation_of_vaccine_status_and_uncertain_effectiveness_of_covid-19_vaccination.pdf
- 2023/04/28 19:45
- 543.8 KB
- mortality_rate_comparisons_between_vaccinated_and_non_vaccinated.pdf
- 2023/04/28 19:45
- 725.7 KB
- negative_quasi-vaccine_efficacy_and_possible_immunological_addiction.pdf
- 2023/04/28 19:45
- 1.8 MB
- randomised_clinical_trials_of_covid-19_vaccines_adenovirus-vector..pdf
- 2023/04/28 19:45
- 297.8 KB
- six_month_safety_and_efficacy_of_the_bnt162b2_mrna_covid-19.pdf
- 2023/04/28 19:45
- 457.6 KB
- six-month_sequelae_of_post-vaccination_sars-cov-2_infection.pdf
- 2023/04/28 19:45
- 1.4 MB
- sources_of_bias_in_observational_studies_of_covid‐19_vaccine_effectiveness.pdf
- 2023/05/21 21:50
- 1.7 MB
- viral_load_among_vaccinated_and_unvaccinated_asymptomatic_and_symptomatic_persons.pdf
- 2024/01/17 22:58
- 511.6 KB
Fichero
- Ver
- Historial
- Fecha:
- 2023/04/28 19:46
- Nombre del archivo:
- safety_and_effectiveness_of_monovalent_covid-19_mrna_vaccination_adolescents.pdf
- Tamaño:
- 800KB
- Referencias para:
- start
- vacunas_en_ninos
gestion_de_la_pandemia.txt · Última modificación: 2024/03/29 20:31 por cv_ev_usr2